A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
Clinical trial NCT06884293 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06884293
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2026-12-31
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.